Evidence map›Paper›PMID 36572861›Full record

ArticleBMC infectious diseases2022

SARS-CoV-2 outbreaks in secondary school settings in the Netherlands during fall 2020; silent circulation.

Lotte Jonker, Kimberly J Linde, Marieke L A de Hoog, Robin Sprado, Robin C Huisman, Richard Molenkamp, Bas B Oude Munnink, Wietske Dohmen, Dick J J Heederik, Dirk Eggink and 6 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Lotte JonkerJulius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands. l.jonker-2@umcutrecht.nl.
Kimberly J LindeInstitute for Risk Assessment Sciences, Utrecht University, Yalelaan 2, 3584 CM, Utrecht, The Netherlands.
Marieke L A de HoogJulius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.
Robin SpradoJulius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.
Robin C HuismanDepartment of Viroscience, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GD, Rotterdam, The Netherlands.
Richard MolenkampDepartment of Viroscience, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GD, Rotterdam, The Netherlands.
Bas B Oude MunninkDepartment of Viroscience, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GD, Rotterdam, The Netherlands.
Wietske DohmenInstitute for Risk Assessment Sciences, Utrecht University, Yalelaan 2, 3584 CM, Utrecht, The Netherlands.
Dick J J HeederikInstitute for Risk Assessment Sciences, Utrecht University, Yalelaan 2, 3584 CM, Utrecht, The Netherlands.
Dirk EgginkCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
Matthijs R A WelkersCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
Harry VennemaCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
Pieter L A FraaijDepartment of Viroscience, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GD, Rotterdam, The Netherlands.
Marion P G KoopmansDepartment of Viroscience, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GD, Rotterdam, The Netherlands.
Inge M WoutersInstitute for Risk Assessment Sciences, Utrecht University, Yalelaan 2, 3584 CM, Utrecht, The Netherlands.
Patricia C J L Bruijning-VerhagenJulius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn fall 2020 when schools in the Netherlands operated under a limited set of COVID-19 measures, we conducted outbreaks studies in four secondary schools to gain insight in the level of school transmission and the role of SARS-CoV-2 transmission via air and surfaces.

methodsOutbreak studies were performed between 11 November and 15 December 2020 when the wild-type variant of SARS-CoV-2 was dominant. Clusters of SARS-CoV-2 infections within schools were identified through a prospective school surveillance study. All school contacts of cluster cases, irrespective of symptoms, were invited for PCR testing twice within 48 h and 4-7 days later. Combined NTS and saliva samples were collected at each time point along with data on recent exposure and symptoms. Surface and active air samples were collected in the school environment. All samples were PCR-tested and sequenced when possible.

resultsOut of 263 sampled school contacts, 24 tested SARS-CoV-2 positive (secondary attack rate 9.1%), of which 62% remained asymptomatic and 42% had a weakly positive test result. Phylogenetic analysis on 12 subjects from 2 schools indicated a cluster of 8 and 2 secondary cases, respectively, but also other distinct strains within outbreaks. Of 51 collected air and 53 surface samples, none were SARS-CoV-2 positive.

conclusionOur study confirmed within school SARS-CoV-2 transmission and substantial silent circulation, but also multiple introductions in some cases. Absence of air or surface contamination suggests environmental contamination is not widespread during school outbreaks.

Indexed as

COVID-19SARS-CoV-2Disease OutbreaksHumansNetherlandsPhylogenyProspective StudiesSchoolsAir levelsOutbreakSARS-CoV-2Secondary schoolsTransmission

Identifiers

PMID36572861
PMCPMC9791966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.